Figure 3From: Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis Survival curve comparing patients with baseline TRACP 5b activity ≥ 5.736 U/L grouped by Δ max TRACP 5b > 38.59% and Δ max TRACP 5b ≤ 38.59% in a Cox-regression model.Back to article page